Sai Life Sciences (NSE:SAILIFE) FCF Margin %: 0.00% (As of Mar. 2026)


NSE:SAILIFE Sai Life Sciences Ltd NSE:SAILIFE
18 GF Score
Price ₹1,221.30
! 4 Warning Signs
View Full Analysis

What is Sai Life Sciences FCF Margin %?

Sai Life Sciences NSE:SAILIFE +1.35% 18 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Sai Life Sciences ranks worse than 54.41% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sai Life Sciences's Free Cash Flow for the three months ended in Mar. 2026 was ₹0 Mil. Sai Life Sciences's Revenue for the three months ended in Mar. 2026 was ₹6,021 Mil. Therefore, Sai Life Sciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Sai Life Sciences's current FCF Yield % is -0.33%.

The historical rank and industry rank for Sai Life Sciences's FCF Margin % or its related term are showing as below:

NSE:SAILIFE' s FCF Margin % Range Over the Past 10 Years
Min: -11.74   Med: -3.26   Max: 8.88
Current: -3.82


During the past 5 years, the highest FCF Margin % of Sai Life Sciences was 8.88%. The lowest was -11.74%. And the median was -3.26%.

NSE:SAILIFE's FCF Margin % is ranked worse than
54.41% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs NSE:SAILIFE: -3.82


Sai Life Sciences FCF Margin % Related Terms


Sai Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Sai Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Life Sciences FCF Margin % Chart

Sai Life Sciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
-11.74 8.88 5.59 -3.26 -3.82

Sai Life Sciences Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:SAILIFE vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Sai Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sai Life Sciences FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sai Life Sciences's FCF Margin % falls into.


NSE:SAILIFE
18GF Score
Sai Life Sciences Ltd NSE:SAILIFE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sai Life Sciences's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-838.28/21924.92
=-3.82 %

Sai Life Sciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/6021.39
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Sai Life Sciences (NSE:SAILIFE) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sai Life Sciences and its competitors. According to the industry distribution chart, Sai Life Sciences ranks #111 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 54.4%.
Is Sai Life Sciences' FCF Margin % too high?
Sai Life Sciences' current FCF Margin % is 0.00%. Based on the distribution chart, Sai Life Sciences ranks #111 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #111 out of 204 companies for FCF Margin %. This places Sai Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sai Life Sciences and its competitors. Sai Life Sciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Sai Life Sciences' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Life Sciences Business Description

Other Exchanges 544306:India
Address Gachibowli Miyapur Road, L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Gachibowli, Hyderabad, TG, IND, 500032
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score

Get the complete analysis for NSE:SAILIFE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,221.30
Price